A higher dependency on glutamine-related ROS detoxyfication activity has been reported for KRAS/LKB1/KEAP1 triple mutants compared to KRAS/LKB1- or KRAS-mutated NSCLC (44). Here, KEAP1 is linked to non-small cell lung carcinoma.